Registered outcomes16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 16 of 16

List	Outcome	Time frame
Primary	Biomarkers of osteoblast and osteoclast activity	Baseline, 2 Years
Secondary	Symptomatic skeletal events (SSEs)	Baseline, 2 Years
Secondary	Time to SSE	Baseline, 2 Years
Secondary	Quality of life using the FKSI-19	Baseline, 2 Years
Secondary	Pain using the Brief Pain Inventory (Short Form)	Baseline, 2 Years
Secondary	Analgesic use	Baseline, 2 Years
Secondary	Overall response rate by RECIST version 1.1	2 Years
Secondary	Duration of response by RECIST version 1.1	2 Years
Secondary	Overall survival	2 Years
Secondary	Progression-free survival	2 Years
Secondary	Response as determined by PERCIST Criteria	2 Years
Secondary	Response as determined by MDA Bone Response Criteria	2 Years
Secondary	Response within bone biomarker subgroups	2 Years
Secondary	Time to first SSE within bone biomarker subgroups	2 Years
Secondary	PFS within bone biomarker subgroups	2 Years
Secondary	OS within bone biomarker subgroups	2 Years

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02406521/registered